HIV/Hepatitis C
Clinical trial to study Ampligen in HIV/hep-C coinfected patients
Published in AIDS Weekly, July 26th, 2004
The company has shipped the total amount of vials of Ampligen, required for the trial, to Esteve.
In March 2002, Hemispherx S.A., a subsidiary of Hemispherx Biopharma, entered into a sales and distribution agreement with Esteve. Pursuant to the terms of the agreement, Esteve was granted the exclusive right to market Ampligen in Spain, Portugal, and Andorra for the treatment of chronic fatigue syndrome.
In...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-07-26)
More Articles from AIDS Weekly
- HIV/AIDS Diagnostics
ViroSeq HIV-1 Genotyping System has decreased performance with non-B subtypes - HIV/AIDS Research
CpG oligodeoxynucleotides activate HIV replication in latently infected T cells - HIV/AIDS Research
Novel HIV inhibitors generated through hybridization of known ligands - HIV/AIDS Therapy
Protamine/AS-ODN nanoparticles may be used to inhibit HIV gene expression - HIV/AIDS-Associated Infection
IFN-gamma activates monocytes for enhanced phagocytosis of M. avium in HIV - AIDS Therapy
Data on Lexiva/Ritonavir vs. Nelfinavir study published - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
